Capstone Wealth Management Group, LLC Gilead Sciences, Inc. Transaction History

Capstone Wealth Management Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	BUY	$73.27 - $83.09 $3,150 - $3,572	43 Added 1.51%	2,891 $234,000
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $15,823 - $17,263	-214 Reduced 6.99%	2,848 $213,000
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $3,648 - $4,161	-48 Reduced 1.54%	3,062 $235,000
Q1 2023 Apr 13, 2023	BUY	$77.31 - $88.08 $13,683 - $15,590	177 Added 6.03%	3,110 $258,000
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $182,784 - $262,415	2,933 New	2,933 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Capstone Wealth Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Wealth Management Group, LLC with notifications on news.